These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 27272851)

  • 1. New Marker Genes for Real-Time PCR-based Detection of Circulating Tumour Cells from Blood of Breast Cancer Patients.
    Kölbl AC; Bräuer D; Hutter S; Rack B; Friese K; Jeschke U; Andergassen U
    Anticancer Res; 2016 Jun; 36(6):3211-6. PubMed ID: 27272851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-time RT-PCR systems for CTC detection from blood samples of breast cancer and gynaecological tumour patients (Review).
    Andergassen U; Kölbl AC; Mahner S; Jeschke U
    Oncol Rep; 2016 Apr; 35(4):1905-15. PubMed ID: 26848098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial‑mesenchymal transition was identified as a potential marker for breast cancer aggressiveness using reverse transcription‑quantitative polymerase chain reaction.
    Andergassen U; Schlenk K; Jeschke U; Sommer H; Kölbl A
    Mol Med Rep; 2018 Aug; 18(2):1733-1739. PubMed ID: 29845200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancer.
    Paoletti C; Muñiz MC; Thomas DG; Griffith KA; Kidwell KM; Tokudome N; Brown ME; Aung K; Miller MC; Blossom DL; Schott AF; Henry NL; Rae JM; Connelly MC; Chianese DA; Hayes DF
    Clin Cancer Res; 2015 Jun; 21(11):2487-98. PubMed ID: 25381338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of tumor cell-specific mRNA in the peripheral blood of patients with breast cancer—evaluation of several markers with real-time reverse transcription-PCR.
    Andergassen U; Hofmann S; Kölbl AC; Schindlbeck C; Neugebauer J; Hutter S; Engelstädter V; Ilmer M; Friese K; Jeschke U
    Int J Mol Sci; 2013 Jan; 14(1):1093-104. PubMed ID: 23299436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can circulating tumor cells predict resistance in metastatic breast cancer?
    Mathew A; Brufsky AM; Davidson NE
    Clin Cancer Res; 2015 Jun; 21(11):2421-3. PubMed ID: 25645864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.
    Obermayr E; Sanchez-Cabo F; Tea MK; Singer CF; Krainer M; Fischer MB; Sehouli J; Reinthaller A; Horvat R; Heinze G; Tong D; Zeillinger R
    BMC Cancer; 2010 Dec; 10():666. PubMed ID: 21129172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.
    Esteva FJ; Sahin AA; Cristofanilli M; Coombes K; Lee SJ; Baker J; Cronin M; Walker M; Watson D; Shak S; Hortobagyi GN
    Clin Cancer Res; 2005 May; 11(9):3315-9. PubMed ID: 15867229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of circulating tumor cells during follow-up of patients with early breast cancer: Clinical utility for monitoring of therapy efficacy.
    Mikulová V; Cabiňaková M; Janatková I; Mestek O; Zima T; Tesařová P
    Scand J Clin Lab Invest; 2014 Mar; 74(2):132-42. PubMed ID: 24350991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Survivin-expressing circulating cancer cells in the peripheral blood of breast cancer patients by a RT-PCR ELISA.
    Yie SM; Luo B; Ye NY; Xie K; Ye SR
    Clin Exp Metastasis; 2006; 23(5-6):279-89. PubMed ID: 17086357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the hormone receptor status of circulating tumor cell subpopulations based on epithelial-mesenchymal transition: a proof-of-principle study on the heterogeneity of circulating tumor cells.
    Guan X; Ma F; Liu S; Wu S; Xiao R; Yuan L; Sun X; Yi Z; Yang H; Xu B
    Oncotarget; 2016 Oct; 7(40):65993-66002. PubMed ID: 27602758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection.
    Pinzani P; Salvadori B; Simi L; Bianchi S; Distante V; Cataliotti L; Pazzagli M; Orlando C
    Hum Pathol; 2006 Jun; 37(6):711-8. PubMed ID: 16733212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating tumor cells (CTCs) detected by triple-marker EpCAM, CK19, and hMAM RT-PCR and their relation to clinical outcome in metastatic breast cancer patients.
    Zhao S; Yang H; Zhang M; Zhang D; Liu Y; Liu Y; Song Y; Zhang X; Li H; Ma W; Zhang Q
    Cell Biochem Biophys; 2013 Mar; 65(2):263-73. PubMed ID: 22990361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of circulating tumor cells from patients with metastatic breast cancer reflects evolutionary changes in gene expression under the pressure of systemic therapy.
    Aaltonen KE; Novosadová V; Bendahl PO; Graffman C; Larsson AM; Rydén L
    Oncotarget; 2017 Jul; 8(28):45544-45565. PubMed ID: 28489591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosyltransferases as marker genes for the quantitative polymerase chain reaction-based detection of circulating tumour cells from blood samples of patients with breast cancer undergoing adjuvant therapy.
    Kölbl AC; Hiller RA; Ilmer M; Liesche F; Heublein S; Schröder L; Hutter S; Friese K; Jeschke U; Andergassen U
    Mol Med Rep; 2015 Aug; 12(2):2933-8. PubMed ID: 25955084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Circulating Tumor Cells in Breast Cancer Patients Using Cytokeratin-19 Real-Time RT-PCR.
    Park HS; Han HJ; Lee S; Kim GM; Park S; Choi YA; Lee JD; Kim GM; Sohn J; Kim SI
    Yonsei Med J; 2017 Jan; 58(1):19-26. PubMed ID: 27873491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies.
    Tewes M; Aktas B; Welt A; Mueller S; Hauch S; Kimmig R; Kasimir-Bauer S
    Breast Cancer Res Treat; 2009 Jun; 115(3):581-90. PubMed ID: 18679793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of circulating tumour cells in early stage breast cancer patients using multi marker immunobead RT-PCR.
    Raynor MP; Stephenson SA; Pittman KB; Walsh DC; Henderson MA; Dobrovic A
    J Hematol Oncol; 2009 Jun; 2():24. PubMed ID: 19500345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of adjuvant chemotherapy in hormone receptor-positive breast cancer patients with or without the 21-gene expression assay.
    Park SJ; Lee MH; Kong SY; Song MK; Joo J; Kwon Y; Lee EG; Han JH; Sim SH; Jung SY; Lee S; Lee KS; Park IH; Lee ES
    Breast Cancer Res Treat; 2018 Jul; 170(1):69-76. PubMed ID: 29516374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients.
    Van der Auwera I; Elst HJ; Van Laere SJ; Maes H; Huget P; van Dam P; Van Marck EA; Vermeulen PB; Dirix LY
    Br J Cancer; 2009 Apr; 100(8):1277-86. PubMed ID: 19367284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.